Filing Details
- Accession Number:
- 0000899243-19-019500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-11 21:00:24
- Reporting Period:
- 2019-07-09
- Accepted Time:
- 2019-07-11 21:00:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754125 | B. Douglas Snyder | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2019-07-09 | 4,968 | $14.42 | 82,920 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on May 14, 2019.
- Represented by American Depositary Shares of the Issuer ("ADSs"). Each ADS represents twelve ordinary shares of the Issuer.
- The price reported in Column 4 is a price per ordinary share converted from price per ADS.
- Includes 56,376 and 26,544 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively.